TNL Mediagene [TNMG] vs John Wiley & Sons [WLYB] Detailed Stock Comparison

TNL Mediagene
NASDAQ
Loading...

John Wiley & Sons
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: TNL Mediagene wins in 6 metrics, John Wiley & Sons wins in 7 metrics, with 0 ties. John Wiley & Sons appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | TNL Mediagene | John Wiley & Sons | Better |
---|---|---|---|
P/E Ratio (TTM) | N/A | 22.86 | N/A |
Price-to-Book Ratio | 0.21 | 2.95 | TNL Mediagene |
Debt-to-Equity Ratio | 0.64 | 126.20 | TNL Mediagene |
PEG Ratio | N/A | -0.03 | N/A |
EV/EBITDA | -0.65 | 9.89 | TNL Mediagene |
Profit Margin (TTM) | 36.58% | 5.82% | TNL Mediagene |
Operating Margin (TTM) | -159.10% | 7.96% | John Wiley & Sons |
EBITDA Margin (TTM) | N/A | 7.96% | N/A |
Return on Equity | -233.51% | 13.45% | John Wiley & Sons |
Return on Assets (TTM) | -91.49% | 5.78% | John Wiley & Sons |
Free Cash Flow (TTM) | $-10.58M | $119.82M | John Wiley & Sons |
1-Year Return | -97.44% | -19.14% | John Wiley & Sons |
Price-to-Sales Ratio (TTM) | 0.20 | 1.30 | TNL Mediagene |
Enterprise Value | $29.03M | $3.01B | John Wiley & Sons |
EV/Revenue Ratio | 0.60 | 1.80 | TNL Mediagene |
Gross Profit Margin (TTM) | N/A | 72.46% | N/A |
Revenue per Share (TTM) | N/A | $31 | N/A |
Earnings per Share (Diluted) | $-3.46 | $1.78 | John Wiley & Sons |
Beta (Stock Volatility) | N/A | 1.04 | N/A |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
TNL Mediagene vs John Wiley & Sons Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
TNL Mediagene | 3.14% | 11.11% | -3.23% | -37.50% | -42.31% | -95.94% |
John Wiley & Sons | 0.00% | 0.00% | 0.43% | -9.38% | -5.32% | -9.17% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
TNL Mediagene | -97.44% | -97.44% | -97.44% | -97.44% | -97.44% | -97.44% |
John Wiley & Sons | -19.14% | 4.19% | 22.95% | -21.68% | -16.63% | -16.63% |
News Based Sentiment: TNL Mediagene vs John Wiley & Sons
TNL Mediagene
News sentiment data is not available for TNL Mediagene at this time.
John Wiley & Sons
News based Sentiment: MIXED
October was a mixed month for John Wiley & Sons, marked by strong financial results that exceeded expectations, but tempered by a stock downgrade, a significant increase in short interest, and governance concerns raised during a shareholder vote. These conflicting signals create a complex investment picture.
Performance & Financial Health Analysis: TNL Mediagene vs John Wiley & Sons
Metric | TNMG | WLYB |
---|---|---|
Market Information | ||
Market Cap | $9.54M | $2.13B |
Market Cap Category | Micro cap | Mid cap |
10 Day Avg. Volume | 10,820,067 | 480 |
90 Day Avg. Volume | 6,992,452 | 551 |
Last Close | $0.30 | $40.02 |
52 Week Range | $0.25 - $34.08 | $37.27 - $52.90 |
% from 52W High | -99.13% | -24.35% |
All-Time High | $34.08 (Dec 02, 2024) | $71.40 (Jun 11, 2018) |
% from All-Time High | -99.12% | -43.95% |
Growth Metrics | ||
Quarterly Revenue Growth | N/A | -0.02% |
Quarterly Earnings Growth | N/A | -0.02% |
Financial Health | ||
Profit Margin (TTM) | 0.37% | 0.06% |
Operating Margin (TTM) | -1.59% | 0.08% |
Return on Equity (TTM) | -2.34% | 0.13% |
Debt to Equity (MRQ) | 0.64 | 126.20 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $1.39 | $13.77 |
Cash per Share (MRQ) | N/A | $1.55 |
Operating Cash Flow (TTM) | $-36,835,261 | $206.30M |
Levered Free Cash Flow (TTM) | $-85,004,692 | $135.97M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: TNL Mediagene vs John Wiley & Sons
Metric | TNMG | WLYB |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | N/A | 22.86 |
Forward P/E | N/A | N/A |
PEG Ratio | N/A | -0.03 |
Price to Sales (TTM) | 0.20 | 1.30 |
Price to Book (MRQ) | 0.21 | 2.95 |
Market Capitalization | ||
Market Capitalization | $9.54M | $2.13B |
Enterprise Value | $29.03M | $3.01B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 0.60 | 1.80 |
Enterprise to EBITDA | -0.65 | 9.89 |
Risk & Other Metrics | ||
Beta | N/A | 1.04 |
Book Value per Share (MRQ) | $1.39 | $13.77 |
Financial Statements Comparison: TNL Mediagene vs John Wiley & Sons
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | TNMG | WLYB |
---|---|---|
Revenue/Sales | N/A | $396.80M |
Cost of Goods Sold | N/A | $109.26M |
Gross Profit | N/A | $287.54M |
Research & Development | N/A | N/A |
Operating Income (EBIT) | N/A | $34.00M |
EBITDA | N/A | $70.32M |
Pre-Tax Income | N/A | $17.71M |
Income Tax | N/A | $6.01M |
Net Income (Profit) | N/A | $11.70M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | TNMG | WLYB |
---|---|---|
Cash & Equivalents | $3.65M | $85.88M |
Total Current Assets | $17.72M | $439.88M |
Total Current Liabilities | $32.99M | $820.86M |
Long-Term Debt | $10.39M | $870.92M |
Total Shareholders Equity | $36.40M | $752.21M |
Retained Earnings | $-117.21M | $1.59B |
Property, Plant & Equipment | $100,203 | $66.13M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | TNMG | WLYB |
---|---|---|
Operating Cash Flow | N/A | $110.07M |
Capital Expenditures | N/A | $-19.13M |
Free Cash Flow | N/A | $125.11M |
Debt Repayment | N/A | $-253.68M |
Common Stock Repurchase | N/A | $-25.00M |
Short Interest & Institutional Ownership Analysis
Metric | TNMG | WLYB |
---|---|---|
Shares Short | 54,828 | 766 |
Short Ratio | 0.02 | 4.82 |
Short % of Float | N/A | 0.00% |
Average Daily Volume (10 Day) | 10,820,067 | 480 |
Average Daily Volume (90 Day) | 6,992,452 | 551 |
Shares Outstanding | 26.13M | 53.39M |
Float Shares | N/A | 40.19M |
% Held by Insiders | 0.00% | 0.94% |
% Held by Institutions | 0.01% | 0.03% |
Dividend Analysis & Yield Comparison: TNL Mediagene vs John Wiley & Sons
Metric | TNMG | WLYB |
---|---|---|
Last 12-Month Dividend | N/A | $0.00 |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | N/A | $0.93 |
3-Year Avg Dividend Yield | N/A | 0.99% |
3-Year Total Dividends | N/A | $2.80 |
Ex-Dividend Date | N/A | Dec 26, 2023 |